Esophageal Varices Clinical Trial
Official title:
Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding
Patients with scarring of the liver (cirrhosis) and portal hypertension (elevated blood pressure in the liver vasculature) can develop esophageal varices (dilated veins). These have an increased risk of bleeding each year. Current recommendations are to prevent bleeding of medium or large varices (when there is no history of bleeding) by starting a blood pressure lowering agent known as a non-selective beta-blocker. Alternatively, rubber bands can be placed on medium to large varices to prevent bleeding (endoscopic variceal band ligation). Using both therapies at the same time has not been studied. In this study, we hope to determine if the use of combination therapy with endoscopic variceal band ligation and beta blockers is more effective than using beta blockers alone to prevent the first bleeding episode from the varices (dilated veins). The efficacy, ability to tolerate, and cost-effectiveness of these two treatment strategies will be compared.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06017102 -
Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices
|
N/A | |
| Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
| Recruiting |
NCT03989973 -
Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
|
||
| Completed |
NCT05485714 -
Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
|
||
| Completed |
NCT01851252 -
MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy
|
Phase 1 | |
| Completed |
NCT01360515 -
A Study of Disposable Transnasal Esophagoscope
|
N/A | |
| Recruiting |
NCT04602663 -
Optimal Time for Follow up After Variceal Band Ligation
|
N/A | |
| Recruiting |
NCT04499898 -
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
|
Phase 2/Phase 3 | |
| Completed |
NCT00331188 -
Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
|
Phase 3 | |
| Enrolling by invitation |
NCT02767206 -
Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.
|
N/A | |
| Enrolling by invitation |
NCT05781828 -
Noninvasive Methods For Prediction of Esophageal Varices in Children
|
||
| Not yet recruiting |
NCT05199038 -
Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study
|
Phase 4 | |
| Recruiting |
NCT02740166 -
Preventing Recurrent Bleeding After Eradication of Esophageal Varices
|
Phase 4 | |
| Completed |
NCT01893541 -
PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?
|
Phase 4 | |
| Terminated |
NCT00485290 -
Effect of Meal on Portal and Esophagus Variceal Pressure
|
N/A | |
| Completed |
NCT01079416 -
Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
|
N/A | |
| Completed |
NCT01188733 -
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT04254822 -
HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients
|
N/A | |
| Recruiting |
NCT03212872 -
Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding
|
N/A | |
| Completed |
NCT03748563 -
Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis
|
N/A |